sábado, 14 de novembro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 28, 2026

OSB GROUP PLC - Transaction in Own Shares

View original at globenewswire.com
OSB GROUP PLC - Transaction in Own Shares OSB GROUP PLC ISIN: GB00BLDRH360 28 January 2026 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares The Company announces that on 27 January 2026 it had purchased a total of 129,500 of its ordinary shares of £0.01 each (the "ordinary shares…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 354,846,712 ordinary shares

    80% confidence

  • No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 354,846,712

    80% confidence

Data points we hold from this source

OSB GROUP PLC · total voting rights354846712 voting_rights
OSB GROUP PLC · stock price low lse616.50 GBp
OSB GROUP PLC · stock price vwap cboe bxe619.49 GBp
OSB GROUP PLC · stock price vwap lse625.09 GBp
OSB GROUP PLC · stock price low cboe bxe616.50 GBp
OSB GROUP PLC · stock price high lse633.50 GBp
OSB GROUP PLC · stock price high cboe bxe626.50 GBp
OSB GROUP PLC · shares purchased lse90000 shares
OSB GROUP PLC · shares purchased cboe bxe39500 shares
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
OSB GROUP PLC - Transaction in Own Shares — Source | Via News | pt.VIA.NEWS